GGrantIndex
← Leaderboards

Shiv Subramaniam Pillai

Massachusetts General Hospital

$21,368,359
Attributed
$21,368,359
Total exposure
20
Grants
17
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.1M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$27,920,996 · 21

By mechanism

U19$11,807,584 · 8
R01$11,624,959 · 6
R21$1,889,852 · 4
RC1$997,373 · 1
T32$947,609 · 1
P30$653,619 · 1

Top collaborators

No co-investigators on record.

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsAutoimmune DiseasesB-LymphocytesBaseImmuneAutoimmunityAutoimmune ProcessEnzymesMolecularProgramsAntigensLinkTissuesIgg4Cd4 Positive T LymphocytesPilot ProjectsPrincipal InvestigatorT-LymphocyteCollaborationsSialic AcidsImmunologySignal TransductionNext Generation SequencingFibrosis

Grant awards (85)

An autoimmune center of excellence for the study of IgG4-related disease$772,936
U19 · FY2025 · AI · contact PI
Principal Project$390,792
U19 · FY2025 · AI · contact PI
Administrative Core$95,537
U19 · FY2025 · AI · contact PI
An autoimmune center of excellence for the study of IgG4-related disease$774,410
U19 · FY2024 · AI · contact PI
Principal Project$334,000
U19 · FY2024 · AI · contact PI
Administrative Core$189,911
U19 · FY2024 · AI · contact PI
Admin-Core-001$638,905
U19 · FY2023 · AI · contact PI
An autoimmune center of excellence for the study of IgG4-related disease$638,905
U19 · FY2023 · AI · contact PI
An autoimmune center of excellence for the study of IgG4-related disease$336,000
U19 · FY2022 · AI · contact PI
Cytotoxic CD4+ T cells and autoimmune fibrotic disorders$252,000
U19 · FY2022 · AI · contact PI
Coordinating an ACE studying IgG4-related diseases$84,000
U19 · FY2022 · AI · contact PI
An autoimmune center of excellence for the study of IgG4-related disease$336,000
U19 · FY2021 · AI · contact PI
Cytotoxic CD4+ T cells and autoimmune fibrotic disorders$251,998
U19 · FY2021 · AI · contact PI
Coordinating an ACE studying IgG4-related diseases$84,000
U19 · FY2021 · AI · contact PI
An autoimmune center of excellence for the study of IgG4-related disease$448,950
U19 · FY2020 · AI · contact PI
Cytotoxic CD4+ T cells and autoimmune fibrotic disorders$252,000
U19 · FY2020 · AI · contact PI
Immunology Core$128,065
P30 · FY2020 · DK · contact PI
Coordinating an ACE studying IgG4-related diseases$84,000
U19 · FY2020 · AI · contact PI
An autoimmune center of excellence for the study of IgG4-related disease$551,046
U19 · FY2019 · AI · contact PI
Cytotoxic CD4+ T cells and autoimmune fibrotic disorders$252,000
U19 · FY2019 · AI · contact PI
Training Program in Immunological Tolerance and Autoimmunity$193,669
T32 · FY2019 · AI · contact PI
Immunology Core$131,207
P30 · FY2019 · DK · contact PI
Coordinating an ACE studying IgG4-related diseases$84,000
U19 · FY2019 · AI · contact PI
An Autoimmune center of excellence for the study of IgG4-related disease$451,878
U19 · FY2018 · AI · contact PI
Studies on the Immunology of IgG4-related diseases$376,567
U19 · FY2018 · AI · contact PI
Training Program in Immunological Tolerance and Autoimmunity$191,544
T32 · FY2018 · AI · contact PI
Immunology Core$128,791
P30 · FY2018 · DK · contact PI
Administrative Core$75,311
U19 · FY2018 · AI · contact PI
An Autoimmune center of excellence for the study of IgG4-related disease$451,878
U19 · FY2017 · AI · contact PI
Studies on the Immunology of IgG4-related diseases$376,566
U19 · FY2017 · AI · contact PI
Training Program in Immunological Tolerance and Autoimmunity$189,470
T32 · FY2017 · AI · contact PI
Immunology Core$132,778
P30 · FY2017 · DK · contact PI
Administrative Core$75,312
U19 · FY2017 · AI · contact PI
An Autoimmune center of excellence for the study of IgG4-related disease$451,878
U19 · FY2016 · AI · contact PI
Studies on Peripheral B Lymphocyte Development$428,640
R01 · FY2016 · AI · contact PI
Immune protection against HIV by induction of CD4+CTLs.$427,500
R01 · FY2016 · AI · contact PI
Studies on the Immunology of IgG4-related diseases$375,283
U19 · FY2016 · AI · contact PI
Training Program in Immunological Tolerance and Autoimmunity$187,448
T32 · FY2016 · AI · contact PI
Immunology Core$132,778
P30 · FY2016 · DK · contact PI
Administrative Core$76,595
U19 · FY2016 · AI · contact PI
An Autoimmune center of excellence for the study of IgG4-related disease$625,878
U19 · FY2015 · AI · contact PI
Studies on Peripheral B Lymphocyte Development$428,640
R01 · FY2015 · AI · contact PI
Studies on the Immunology of IgG4-related diseases$392,831
U19 · FY2015 · AI · contact PI
Training Program in Immunological Tolerance and Autoimmunity$185,478
T32 · FY2015 · AI · contact PI
Administrative Core$77,014
U19 · FY2015 · AI · contact PI
An Autoimmune center of excellence for the study of IgG4-related disease$712,878
U19 · FY2014 · AI · contact PI
Studies on Peripheral B Lymphocyte Development$428,640
R01 · FY2014 · AI · contact PI
Studies on the Immunology of IgG4-related diseases$361,225
U19 · FY2014 · AI · contact PI
Administrative Core$75,100
U19 · FY2014 · AI · contact PI
Inducing neutralizing antibodies to HIV by inhibiting SIAE$557,145
R01 · FY2013 · AI · contact PI
Studies on Peripheral B Lymphocyte Development$402,922
R01 · FY2013 · AI · contact PI
Inducing neutralizing antibodies to HIV by inhibiting SIAE$904,644
R01 · FY2012 · AI · contact PI
Mutations in the SIAE Gene and Susceptibility to Autoimmune Diseases$438,075
R01 · FY2012 · AI · contact PI
Studies on Peripheral B Lymphocyte Development$428,640
R01 · FY2012 · AI · contact PI
Inducing neutralizing antibodies to HIV by inhibiting SIAE$671,523
R01 · FY2011 · AI · contact PI
Mutations in the SIAE Gene and Susceptibility to Autoimmune Diseases$438,075
R01 · FY2011 · AI · contact PI
Human Memory B cells in Humanized Mice$219,038
R21 · FY2011 · AI · contact PI
Inducing neutralizing antibodies to HIV by inhibiting SIAE$637,431
R01 · FY2010 · AI · contact PI
Functionally Linking Autoimmune Subjects to Novel Therapies Using Biomarkers$497,602
RC1 · FY2010 · AR · contact PI
Mutations in the SIAE Gene and Susceptibility to Autoimmune Diseases$442,500
R01 · FY2010 · AI · contact PI
Human Memory B cells in Humanized Mice$265,500
R21 · FY2010 · AI · contact PI
Mutations in the SIAE Gene and Susceptibility to Autoimmune Diseases$28,674
R01 · FY2010 · AI · contact PI
Functionally Linking Autoimmune Subjects to Novel Therapies Using Biomarkers$499,771
RC1 · FY2009 · AR · contact PI
Mutations in the SIAE Gene and Susceptibility to Autoimmune Diseases$441,458
R01 · FY2009 · AI · contact PI
Studies on peripheral B lymphocyte development$360,779
R01 · FY2009 · AI · contact PI
Studies on peripheral B lymphocyte development$158,227
R01 · FY2009 · AI · contact PI
Studies on peripheral B lymphocyte development$19,008
R01 · FY2009 · AI · contact PI
Studies on peripheral B lymphocyte development$490,015
R01 · FY2008 · AI · contact PI
Molecular identification of a sialyl 9-O-acetyl transferase$214,594
R21 · FY2008 · AI · contact PI
Studies on peripheral B lymphocyte development$26,257
R01 · FY2008 · AI · contact PI
Studies on peripheral B lymphocyte development$367,766
R01 · FY2007 · AI · contact PI
The role of PKK in NFkappa B activation$352,658
R01 · FY2007 · CA · contact PI
Molecular identification of a sialyl 9-O-acetyl transferase$262,500
R21 · FY2007 · AI · contact PI
Studies on peripheral B lymphocyte development$378,750
R01 · FY2006 · AI · contact PI
The role of PKK in NFkappa B activation$363,191
R01 · FY2006 · CA · contact PI
The role of PKK in NFkappa B activation$371,931
R01 · FY2005 · CA
Studies on human peripheral B lymphocytes$175,000
R21 · FY2005 · AI
The role of PKK in NFkappa B activation$371,931
R01 · FY2004 · CA
Marginal zone B lymphocytes and blood borne pathogens$289,610
R21 · FY2004 · AI
Studies on human peripheral B lymphocytes$174,000
R21 · FY2004 · AI
The role of PKK in NFkappa B activation$371,931
R01 · FY2003 · CA
Marginal zone B lymphocytes and blood borne pathogens$289,610
R21 · FY2003 · AI
MEMBRANE IMMUNOGLOBULIN ASSEMBLY AND FUNCTION$304,794
R01 · FY2002 · AI
MEMBRANE IMMUNOGLOBULIN ASSEMBLY AND FUNCTION$295,917
R01 · FY2001 · AI
MEMBRANE IMMUNOGLOBULIN ASSEMBLY AND FUNCTION$287,297
R01 · FY2000 · AI